sel-11 and cdc-42, two negative modulators of LIN-12/Notch activity in C. elegans

Min Sung Choi1, Andrew S Yoo, Iva Greenwald

  • 1Department of Biological Sciences, Howard Hughes Medical Institute, Columbia University College of Physicians and Surgeons, New York, New York, United States of America.

Plos One
|August 6, 2010
PubMed
Abstract

Insights

Researchers identified two negative regulators of LIN-12/Notch signaling in C. elegans, SEL-11 and CDC-42. These findings reveal new mechanisms for controlling cell fate and offer insights into cancer development.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Cancer Research

Background:

  • LIN-12/Notch signaling is crucial for cell-cell communication in development.
  • Dysregulated LIN-12/Notch signaling, due to loss of negative regulators, is implicated in cancer genesis and progression.

Purpose of the Study:

  • To identify and characterize negative modulators of LIN-12/Notch activity in C. elegans.
  • To explore the role of these modulators in cell fate specification and their potential link to cancer.

Main Methods:

  • Genetic screening in C. elegans to identify suppressors of lin-12 mutations.
  • Characterization of the identified genes, sel-11 and cdc-42, using genetic and molecular approaches.
  • Comparative analysis of SEL-11 with yeast Hrd1p and mammalian Synoviolin.

Main Results:

  • Two negative regulators of lin-12 activity, sel-11 and cdc-42, were identified in C. elegans.
  • SEL-11 was found to be homologous to yeast Hrd1p and mammalian Synoviolin.
  • CDC-42 demonstrated genetic properties consistent with negative regulation of lin-12 during vulval precursor cell fate specification.

Conclusions:

  • Multiple negative regulatory mechanisms control LIN-12/Notch pathway activity.
  • These findings suggest novel pathways through which aberrant LIN-12/Notch signaling may contribute to cancer.

Related Concept Videos